Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Insomnia in Early-Onset Dementia
NCT06093126Phase 4Recruiting
- Sponsor
- Nova Scotia Health
- Start
- Dec 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind, single-arm trial of lemborexant in Insomnia, sponsored by Nova Scotia Health. Primary endpoints: Total Sleep Time, Sleep Onset Latency and 5 more. Started Dec 2023; status: recruiting.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06093126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06093126.